Massimiliano Pau1, Giancarlo Coghe2, Federica Corona3, Maria Giovanna Marrosu2, Eleonora Cocco2. 1. Department of Mechanical, Chemical and Materials Engineering, University of Cagliari, Cagliari, Italy. Electronic address: massimiliano.pau@dimcm.unica.it. 2. Multiple Sclerosis Center, Department of Public Health, Clinical and Molecular Medicine University of Cagliari, Cagliari, Italy. 3. Department of Mechanical, Chemical and Materials Engineering, University of Cagliari, Cagliari, Italy; Multiple Sclerosis Center, Department of Public Health, Clinical and Molecular Medicine University of Cagliari, Cagliari, Italy.
Abstract
PURPOSE: This study proposes to characterize the gait patterns of individuals with Multiple Sclerosis (MS) affected by spasticity using quantitative gait analysis. METHOD: Cross-sectional study on 38 individuals with MS, 19 affected by lower limb spasticity and 19 not affected, the latter forming the control group. Both groups were evaluated while walking using three-dimensional gait analysis. Spatio-temporal parameters of gait, kinematic data expressed by means of Gait Profile Score (GPS) and Range of Motion (ROM), as well as muscular activation, were evaluated. RESULTS: The results show that spasticity originates a peculiar gait pattern characterized by reduced speed, cadence, stride length, swing phase and increased double support time, but they also reveal specific alterations in kinematics and muscular activation. In particular, significantly higher values of GPS, reduced hip and knee flexion-extension ROM and abnormal activation of the rectus femoris were observed in individuals with spasticity. CONCLUSIONS: In people with MS presenting spastic gait, the availability of quantitative data appears crucial in verifying the effectiveness of pharmacologic and rehabilitative treatments, also considering that spasticity scales may not be satisfactory in relating the assessed spasticity with both perception of the patients and the actual body functionalities.
PURPOSE: This study proposes to characterize the gait patterns of individuals with Multiple Sclerosis (MS) affected by spasticity using quantitative gait analysis. METHOD: Cross-sectional study on 38 individuals with MS, 19 affected by lower limb spasticity and 19 not affected, the latter forming the control group. Both groups were evaluated while walking using three-dimensional gait analysis. Spatio-temporal parameters of gait, kinematic data expressed by means of Gait Profile Score (GPS) and Range of Motion (ROM), as well as muscular activation, were evaluated. RESULTS: The results show that spasticity originates a peculiar gait pattern characterized by reduced speed, cadence, stride length, swing phase and increased double support time, but they also reveal specific alterations in kinematics and muscular activation. In particular, significantly higher values of GPS, reduced hip and knee flexion-extension ROM and abnormal activation of the rectus femoris were observed in individuals with spasticity. CONCLUSIONS: In people with MS presenting spastic gait, the availability of quantitative data appears crucial in verifying the effectiveness of pharmacologic and rehabilitative treatments, also considering that spasticity scales may not be satisfactory in relating the assessed spasticity with both perception of the patients and the actual body functionalities.
Authors: Jordan J Craig; Adam P Bruetsch; Sharon G Lynch; Jessie M Huisinga Journal: Clin Biomech (Bristol, Avon) Date: 2017-07-28 Impact factor: 2.063
Authors: Andrew C Smith; Kenneth A Weber; Denise R O'Dell; Todd B Parrish; Marie Wasielewski; James M Elliott Journal: Arch Phys Med Rehabil Date: 2017-10-26 Impact factor: 3.966
Authors: Linard Filli; Tabea Sutter; Christopher S Easthope; Tim Killeen; Christian Meyer; Katja Reuter; Lilla Lörincz; Marc Bolliger; Michael Weller; Armin Curt; Dominik Straumann; Michael Linnebank; Björn Zörner Journal: Sci Rep Date: 2018-03-21 Impact factor: 4.379
Authors: Luis Andreu-Caravaca; Domingo J Ramos-Campo; Linda H Chung; Pedro Manonelles; Oriol Abellán-Aynés; Jacobo Á Rubio-Arias Journal: Biomed Res Int Date: 2021-10-21 Impact factor: 3.411